BOT 0.00% 37.0¢ botanix pharmaceuticals ltd

Bot Chart, page-7422

  1. 321 Posts.
    lightbulb Created with Sketch. 183
    clarence young left in March too, interesting he came across from Novartis, got QIDP for a second indication for kidney patients, Novartis has done a couple of multi-billion dollar deals this year for kidney treatments, then when we “substantially derisked” in March he moved on. Things that make ya go hmm
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.